<DOC>
	<DOC>NCT01425398</DOC>
	<brief_summary>High-dose statin therapy around the time of surgery, decreases inflammation in patients undergoing cardiac valve surgery, and thereby improves clinical outcomes.</brief_summary>
	<brief_title>A Trial to Evaluate the Effect of Rosuvastatin on Inflammation in Patients Undergoing Isolated Cardiac Valve Surgery</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Single or multiple valve repairs or replacements without coronary artery bypass grafting Bentall procedure, but no other aortic procedures With or without accompanying MAZE procedure Age under 18 years old Urgent or emergency surgery Unable to provide consent Presently on statin therapy or exposure to statins within a month of surgery Chronic antiinflammatory use, including steroids and NSAID's (not to be used during the treatment period) Known hypersensitivity to rosuvastatin Active liver disease Indicated by AST/ALT higher than 3 times the upper limit of normal Pregnant or nursing women On drugs with interactions (Cyclosporine, gemfibrozil, lopinavir/ritonavir or atazanavir/ritonavir, niacin) Severe renal impairment not on dialysis Creatinine clearance &lt; 30 ml/min/1.73 m2 Known myopathy and inflammatory diasthesis (such as systemic lupus erythromatosus, rheumatoid arthritis, and inflammatory bowel disease) Human Immunodeficiency Virus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>